Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check2 days agoChange DetectedThe history now includes Revision: v3.5.4, replacing Revision: v3.5.3; this indicates a small software update for ClinicalTrials.gov without altering study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s displayed software/interface revision updates from version v3.5.2 to v3.5.3, without changing the underlying study record content.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision v3.5.0 was added to the Record History and revision v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange Detected- Added revision v3.4.3 to the Record History and removed v3.4.2, updating the page to reflect the latest revision.SummaryDifference0.1%

- Check94 days agoChange DetectedThe record history now includes a new entry, Revision: v3.4.2, and older notices (including the funding notice and Revision: v3.4.1) have been removed.SummaryDifference0.6%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.